Qingdao Vland Biotech INC. (SHA:603739)

SHA:603739 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,005	3,034	3,851	3,387	4,689	3,474
Market Cap Growth	30.50%	-21.22%	13.69%	-27.76%	34.98%	-12.09%
Enterprise Value	4,378	3,413	4,153	3,512	4,417	3,328
Last Close Price	15.83	11.90	15.01	13.14	18.01	15.41
PE Ratio	47.76	48.44	47.72	48.50	35.37	31.88
Forward PE	47.97	30.10	29.41	29.50	-	-
PS Ratio	2.88	2.30	3.21	2.91	4.07	3.62
PB Ratio	2.11	1.62	2.11	1.95	2.78	3.12
P/TBV Ratio	2.56	1.99	2.59	2.28	3.23	3.85
P/FCF Ratio	49.75	33.45	-	-	-	-
P/OCF Ratio	24.13	15.53	25.07	35.54	52.38	20.08
EV/Sales Ratio	3.15	2.58	3.46	3.02	3.84	3.47
EV/EBITDA Ratio	17.27	15.18	23.48	24.16	24.35	21.52
EV/EBIT Ratio	37.84	29.83	40.27	44.08	34.05	29.77
EV/FCF Ratio	54.38	37.64	-	-	-	-
Debt / Equity Ratio	0.36	0.34	0.40	0.30	0.14	0.06
Debt / EBITDA Ratio	2.70	2.83	4.09	3.60	1.30	0.44
Debt / FCF Ratio	8.50	7.01	-	-	-	-
Asset Turnover	0.46	0.44	0.43	0.49	0.63	0.70
Inventory Turnover	3.84	3.69	3.42	4.01	4.40	4.29
Quick Ratio	0.85	0.83	0.82	1.19	2.08	2.06
Current Ratio	1.08	1.04	1.03	1.50	2.61	2.72
Return on Equity (ROE)	6.07%	4.99%	5.78%	5.00%	10.72%	11.39%
Return on Assets (ROA)	2.38%	2.38%	2.30%	2.08%	4.42%	5.11%
Return on Invested Capital (ROIC)	4.11%	4.19%	4.50%	4.07%	9.99%	12.61%
Return on Capital Employed (ROCE)	5.80%	5.90%	5.30%	4.10%	7.00%	9.50%
Earnings Yield	2.09%	2.07%	2.10%	2.06%	2.83%	3.14%
FCF Yield	2.01%	2.99%	-1.61%	-7.28%	-8.62%	-1.12%
Dividend Yield	0.64%	0.84%	0.67%	0.76%	0.89%	0.93%
Payout Ratio	61.82%	88.18%	49.28%	75.55%	28.50%	29.87%
Buyback Yield / Dilution	1.15%	0.66%	2.50%	-5.36%	-8.14%	-6.37%
Total Shareholder Return	1.79%	1.50%	3.16%	-4.60%	-7.25%	-5.45%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.